Taresco Vincenzo, Louzao Iria, Scurr David, Booth Jonathan, Treacher Kevin, McCabe James, Turpin Eleanor, Laughton Charles A, Alexander Cameron, Burley Jonathan C, Garnett Martin C
School of Pharmacy, University of Nottingham , University Park, Nottingham NG7 2RD, U.K.
AstraZeneca , Macclesfield SK10 RNA, U.K.
Mol Pharm. 2017 Jun 5;14(6):2079-2087. doi: 10.1021/acs.molpharmaceut.7b00182. Epub 2017 May 19.
A miniaturized, high-throughput assay was optimized to screen polymer-drug solid dispersions using a 2-D Inkjet printer. By simply printing nanoliter amounts of polymer and drug solutions onto an inert surface, drug/polymer microdots of tunable composition were produced in an easily addressable microarray format. The amount of material printed for each dried spot ranged from 25 ng to 650 ng. These arrays were used to assess the stability of drug/polymer dispersions with respect to recrystallization, using polarized light microscopy. One array with a panel of 6 drugs formulated at different ratios with a poly(vinylpyrrolidone-vinyl acetate) (PVPVA) copolymer was developed to estimate a possible bulk (gram-scale) approximation threshold from the final printed nanoamount of formulation. Another array was printed at a fixed final amount of material to establish a literature comparison of one drug formulated with different commercial polymers for validation. This new approach may offer significant efficiency in pharmaceutical formulation screening, with each experiment in the nanomicro-array format requiring from 3 up to 6 orders of magnitude lower amounts of sample than conventional screening methods.
一种小型化的高通量检测方法通过二维喷墨打印机进行了优化,用于筛选聚合物-药物固体分散体。通过简单地将纳升级的聚合物和药物溶液打印到惰性表面上,以易于寻址的微阵列形式制备了组成可调的药物/聚合物微点。每个干燥点打印的材料量范围为25纳克至650纳克。使用偏光显微镜,这些阵列用于评估药物/聚合物分散体相对于重结晶的稳定性。开发了一个阵列,其中包含6种药物与聚(乙烯基吡咯烷酮-醋酸乙烯酯)(PVPVA)共聚物以不同比例配制,以从最终打印的纳克级制剂中估计可能的批量(克级)近似阈值。另一个阵列以固定的最终材料量进行打印,以建立一种药物与不同商业聚合物配制的文献比较以进行验证。这种新方法可能在药物制剂筛选中提供显著的效率提升,纳米微阵列形式的每个实验所需的样品量比传统筛选方法低3至6个数量级。